share_log

HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Raises Price Target to $24

HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Raises Price Target to $24

HC Wainwright & Co.维持对Caribou Biosciences的买入,将目标股价上调至24美元
Moomoo 24/7 ·  03/19 06:26

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and raises the price target from $23 to $24.

HC Wainwright & Co. 分析师罗伯特·伯恩斯维持Caribou Biosciences(纳斯达克股票代码:CRBU)的买入并将目标股价从23美元上调至24美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发